DayTwo is a microbiome-based precision health company. It creates individualized solutions for chronic conditions, starting with diabetes, prediabetes, and clinical obesity. Using the highest resolution microbiome analysis and a proprietary AI-driven algorithm, DayTwo predicts blood sugar responses to foods or combinations before a single bite. The approach is clinically proven and powered by the company’s unique microbiome dataset, with over 85,000 samples., It is one of the largest and richest in the world.